Plasma, gathered mainly from paid donations in the US, is the raw ingredient needed to produce CSL’s suite of lifesaving products, including its immunoglobulins, conventional haemophilia treatment and ...
Gift 5 articles to anyone you choose each month when you subscribe. Global biotech CSL says its US vaccines business will recover in the medium term when falling immunisation rates trigger a severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback